TY - STD TI - Hannan MA, Al-Dakan AA, Hussain SS, Amer MH. Mutagenicity of cisplatin and carboplatin used alone and in combination with four other anticancer drugs. Toxicology. 1989; 55(1-2):183–91. https://doi.org/10.1016/0300-483x(89)90185-6. UR - https://doi.org/10.1016/0300-483x(89)90185-6 ID - ref1 ER - TY - STD TI - Anderson D, Bishop JB, Garner RC, Ostrosky-Wegman P, Selby PB. Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks. Mutat Res Fundam Mol Mech Mutagen. 1995; 330(1-2):115–81. https://doi.org/10.1016/0027-5107(95)00039-l. UR - https://doi.org/10.1016/0027-5107(95)00039-l ID - ref2 ER - TY - JOUR AU - Nakanomyo, H. AU - Hiraoka, M. AU - Shiraya, M. PY - 1986 DA - 1986// TI - Mutagenicity tests of etoposide and teniposide JO - J Toxicol Sci VL - 11 UR - https://doi.org/10.2131/jts.11.SupplementI_301 DO - 10.2131/jts.11.SupplementI_301 ID - Nakanomyo1986 ER - TY - STD TI - Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, McMichael JF, Wallis JW, Lu C, Shen D, Harris CC, Dooling DJ, Fulton RS, Fulton LL, Chen K, Schmidt H, Kalicki-Veizer J, Magrini VJ, Cook L, McGrath SD, Vickery TL, Wendl MC, Heath S, Watson MA, Link DC, Tomasson MH, Shannon WD, Payton JE, Kulkarni S, Westervelt P, Walter MJ, Graubert TA, Mardis ER, Wilson RK, DiPersio JF. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012; 481(7382):506–10. https://doi.org/10.1038/nature10738. UR - https://doi.org/10.1038/nature10738 ID - ref4 ER - TY - STD TI - Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJM, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2013; 343(6167):189–93. https://doi.org/10.1126/science.1239947. UR - https://doi.org/10.1126/science.1239947 ID - ref5 ER - TY - STD TI - Murugaesu N, Wilson GA, Birkbak NJ, Watkins TBK, McGranahan N, Kumar S, Abbassi-Ghadi N, Salm M, Mitter R, Horswell S, Rowan A, Phillimore B, Biggs J, Begum S, Matthews N, Hochhauser D, Hanna GB, Swanton C. Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy. Cancer Discov. 2015; 5(8):821–31. https://doi.org/10.1158/2159-8290.cd-15-0412. UR - https://doi.org/10.1158/2159-8290.cd-15-0412 ID - ref6 ER - TY - STD TI - Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013; 39(1):1–10. https://doi.org/10.1016/j.immuni.2013.07.012. UR - https://doi.org/10.1016/j.immuni.2013.07.012 ID - ref7 ER - TY - STD TI - Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science. 2015; 348(6230):69–74. https://doi.org/10.1126/science.aaa4971. UR - https://doi.org/10.1126/science.aaa4971 ID - ref8 ER - TY - STD TI - Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, Ohtani H, Old LJ, Odunsi K. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A. 2005; 102(51):18538–43. https://doi.org/10.1073/pnas.0509182102. UR - https://doi.org/10.1073/pnas.0509182102 ID - ref9 ER - TY - STD TI - Hamanishi J, Mandai M, Iwasaki M, Okazaki T, Tanaka Y, Yamaguchi K, Higuchi T, Yagi H, Takakura K, Minato N, Honjo T, Fujii S. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proc Natl Acad Sci U S A. 2007; 104(9):3360–5. https://doi.org/10.1073/pnas.0611533104. UR - https://doi.org/10.1073/pnas.0611533104 ID - ref10 ER - TY - STD TI - Lundegaard C, Lund O, Kesmir C, Brunak S, Nielsen M. Modeling the adaptive immune system: predictions and simulations. Bioinformatics. 2007; 23(24):3265–75. https://doi.org/10.1093/bioinformatics/btm471. UR - https://doi.org/10.1093/bioinformatics/btm471 ID - ref11 ER - TY - STD TI - Brown SD, Warren RL, Gibb EA, Martin SD, Spinelli JJ, Nelson BH, Holt RA. Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival. Genome Res. 2014; 24(5):743–50. https://doi.org/10.1101/gr.165985.113. UR - https://doi.org/10.1101/gr.165985.113 ID - ref12 ER - TY - STD TI - Allen EMV, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, Sucker A, Hillen U, Foppen MHG, Goldinger SM, Utikal J, Hassel JC, Weide B, Kaehler KC, Loquai C, Mohr P, Gutzmer R, Dummer R, Gabriel S, Wu CJ, Schadendorf D, Garraway LA. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science. 2015; 350(6257):207–11. https://doi.org/10.1126/science.aad0095. UR - https://doi.org/10.1126/science.aad0095 ID - ref13 ER - TY - STD TI - Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, Lee W, Yuan J, Wong P, Ho TS, Miller ML, Rekhtman N, Moreira AL, Ibrahim F, Bruggeman C, Gasmi B, Zappasodi R, Maeda Y, Sander C, Garon EB, Merghoub T, Wolchok JD, Schumacher TN, Chan TA. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015; 348(6230):124–8. https://doi.org/10.1126/science.aaa1348. UR - https://doi.org/10.1126/science.aaa1348 ID - ref14 ER - TY - STD TI - Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, Kiezun A, Hammerman PS, McKenna A, Drier Y, Zou L, Ramos AH, Pugh TJ, Stransky N, Helman E, Kim J, Sougnez C, Ambrogio L, Nickerson E, Shefler E, Cortés ML, Auclair D, Saksena G, Voet D, Noble M, DiCara D, Lin P, Lichtenstein L, Heiman DI, Fennell T, Imielinski M, Hernandez B, Hodis E, Baca S, Dulak AM, Lohr J, Landau DA, Wu CJ, Melendez-Zajgla J, Hidalgo-Miranda A, Koren A, McCarroll SA, Mora J, Lee RS, Crompton B, Onofrio R, Parkin M, Winckler W, Ardlie K, Gabriel SB, Roberts CWM, Biegel JA, Stegmaier K, Bass AJ, Garraway LA, Meyerson M, Golub TR, Gordenin DA, Sunyaev S, Lander ES, Getz G. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013; 499(7457):214–8. https://doi.org/10.1038/nature12213. UR - https://doi.org/10.1038/nature12213 ID - ref15 ER - TY - STD TI - Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, Kassahn KS, Newell F, Quinn MCJ, Kazakoff S, Quek K, Wilhelm-Benartzi C, Curry E, Leong HS, Hamilton A, Mileshkin L, Au-Yeung G, Kennedy C, Hung J, Chiew YE, Harnett P, Friedlander M, Quinn M, Pyman J, Cordner S, O’Brien P, Leditschke J, Young G, Strachan K, Waring P, Azar W, Mitchell C, Traficante N, Hendley J, Thorne H, Shackleton M, Miller DK, Arnau GM, Tothill RW, Holloway TP, Semple T, Harliwong I, Nourse C, Nourbakhsh E, Manning S, Idrisoglu S, Bruxner TJC, Christ AN, Poudel B, Holmes O, Anderson M, Leonard C, Lonie A, Hall N, Wood S, Taylor DF, Xu Q, Fink JL, Waddell N, Drapkin R, Stronach E, Gabra H, Brown R, Jewell A, Nagaraj SH, Markham E, Wilson PJ, Ellul J, McNally O, Doyle MA, Vedururu R, Stewart C, Lengyel E, Pearson JV, Waddell N, deFazio A, Grimmond SM, Bowtell DDL. Whole–genome characterization of chemoresistant ovarian cancer. Nature. 2015; 521(7553):489–94. https://doi.org/10.1038/nature14410. UR - https://doi.org/10.1038/nature14410 ID - ref16 ER - TY - STD TI - Boegel S, Lower M, Schafer M, Bukur T, de Graaf J, Boisguérin V, Tureci O, Diken M, Castle JC, Sahin U. HLA typing from RNA-Seq sequence reads. Genome Med. 2012; 4(12):102. https://doi.org/10.1186/gm403. UR - https://doi.org/10.1186/gm403 ID - ref17 ER - TY - STD TI - Szolek A, Schubert B, Mohr C, Sturm M, Feldhahn M, Kohlbacher O. OptiType: precision HLA typing from next-generation sequencing data. Bioinformatics. 2014; 30(23):3310–6. https://doi.org/10.1093/bioinformatics/btu548. UR - https://doi.org/10.1093/bioinformatics/btu548 ID - ref18 ER - TY - STD TI - Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, Nielsen M. NetMHC-3.0: accurate web accessible predictions of human mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res. 2008; 36(Web Server):509–12. https://doi.org/10.1093/nar/gkn202. UR - https://doi.org/10.1093/nar/gkn202 ID - ref19 ER - TY - STD TI - Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Børresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils R, Eyfjörd JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinski M, Imielinsk M, Jäger N, Jones DTW, Jones D, Knappskog S, Kool M, Lakhani SR, López-Otín C, Martin S, Munshi NC, Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, Totoki Y, Tutt ANJ, Valdés-Mas R, van Buuren MM, van ’t Veer L, Vincent-Salomon A, Waddell N, Yates LR, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P, Meyerson M, Grimmond SM, Siebert R, Campo E, Shibata T, Pfister SM, Campbell PJ, Stratton MR. Signatures of mutational processes in human cancer. Nature. 2013; 500(7463):415–21. https://doi.org/10.1038/nature12477. UR - https://doi.org/10.1038/nature12477 ID - ref20 ER - TY - STD TI - Rosenthal R, McGranahan N, Herrero J, Taylor BS, Swanton C. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 2016;17(1). https://doi.org/10.1186/s13059-016-0893-4. UR - https://doi.org/10.1186/s13059-016-0893-4 ID - ref21 ER - TY - STD TI - Meier B, Cooke SL, Weiss J, Bailly AP, Alexandrov LB, Marshall J, Raine K, Maddison M, Anderson E, Stratton MR, Gartner A, Campbell PJ. C. elegans whole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency. Genome Res. 2014; 24(10):1624–36. https://doi.org/10.1101/gr.175547.114. UR - https://doi.org/10.1101/gr.175547.114 ID - ref22 ER - TY - STD TI - Szikriszt B, Póti Á, Pipek O, Krzystanek M, Kanu N, Molnár J, Ribli D, Szeltner Z, Tusnády GE, Csabai I, Szallasi Z, Swanton C, Szüts D. A comprehensive survey of the mutagenic impact of common cancer cytotoxics. Genome Biol. 2016;17(1). https://doi.org/10.1186/s13059-016-0963-7. UR - https://doi.org/10.1186/s13059-016-0963-7 ID - ref23 ER - TY - STD TI - Atsushi H, Shuji S, Kosuke A, Takafumi K. A comparison of in vitro platinum-dna adduct formation between carboplatin and cisplatin. Int J Biochem. 1994; 26(8):1009–16. https://doi.org/10.1016/0020-711X(94)90072-8. UR - https://doi.org/10.1016/0020-711X(94)90072-8 ID - ref24 ER - TY - STD TI - Gelman A, Lee D, Guo J. Stan: A Probabilistic Programming Language for Bayesian Inference and Optimization. J Educ Behav Stat. 2015; 40(5):530–43. https://doi.org/10.3102/1076998615606113. UR - https://doi.org/10.3102/1076998615606113 ID - ref25 ER - TY - STD TI - Institute WTS. Signatures of Mutational Processes in Human Cancer. 2016. Online; Accessed 27 May 2016. ID - ref26 ER - TY - JOUR AU - Dobin, A. AU - Davis, C. A. AU - Schlesinger, F. AU - Drenkow, J. AU - Zaleski, C. AU - Jha, S. AU - Batut, P. AU - Chaisson, M. AU - Gingeras, T. R. PY - 2013 DA - 2013// TI - Star: ultrafast universal rna-seq aligner JO - Bioinformatics VL - 29 UR - https://doi.org/10.1093/bioinformatics/bts635 DO - 10.1093/bioinformatics/bts635 ID - Dobin2013 ER - TY - JOUR AU - Trapnell, C. AU - Williams, B. A. AU - Pertea, G. AU - Mortazavi, A. AU - Kwan, G. AU - van Baren, M. J. AU - Salzberg, S. L. AU - Wold, B. J. AU - Pachter, L. PY - 2010 DA - 2010// TI - Transcript assembly and quantification by rna-seq reveals unannotated transcripts and isoform switching during cell differentiation JO - Nat Biotech VL - 28 UR - https://doi.org/10.1038/nbt.1621 DO - 10.1038/nbt.1621 ID - Trapnell2010 ER - TY - JOUR AU - Newman, A. M. AU - Liu, C. L. AU - Green, M. R. AU - Gentles, A. J. AU - Feng, W. AU - Xu, Y. AU - Hoang, C. D. AU - Diehn, M. AU - Alizadeh, A. A. PY - 2015 DA - 2015// TI - Robust enumeration of cell subsets from tissue expression profiles JO - Nat Meth VL - 12 UR - https://doi.org/10.1038/nmeth.3337 DO - 10.1038/nmeth.3337 ID - Newman2015 ER - TY - JOUR AU - Sette, A. AU - Vitiello, A. AU - Reherman, B. AU - Fowler, P. AU - Nayersina, R. AU - Kast, W. M. AU - Melief, C. J. AU - Oseroff, C. AU - Yuan, L. AU - Ruppert, J. AU - Sidney, J. AU - del Guercio, M. F. AU - Southwood, S. AU - Kubo, R. T. AU - Chesnut, R. W. AU - Grey, H. M. AU - Chisari, F. V. PY - 1994 DA - 1994// TI - The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes JO - J Immunol (Baltimore, Md. : 1950) VL - 153 ID - Sette1994 ER - TY - STD TI - Drerup JM, Liu Y, Padron AS, Murthy K, Hurez V, Zhang B, Curiel TJ. Immunotherapy for ovarian cancer. Curr Treat Options Oncol. 2015; 16(1):317. https://doi.org/10.1007/s11864-014-0317-1. UR - https://doi.org/10.1007/s11864-014-0317-1 ID - ref31 ER - TY - STD TI - Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Yokode M, Shimizu A, Honjo T, Konishi I. Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2015; 33(34):4015–22. https://doi.org/10.1200/JCO.2015.62.3397. UR - https://doi.org/10.1200/JCO.2015.62.3397 ID - ref32 ER - TY - STD TI - Disis ML, Patel MR, Pant S, Hamilton EP, Lockhart AC, Kelly K, Beck JT, Gordon MS, Weiss GJ, Taylor MH, Chaves J, Mita AC, Chin KM, von Heydebreck A, Cuillerot JM, Gulley JL. Avelumab (msb0010718c; anti-pd-l1) in patients with recurrent/refractory ovarian cancer from the javelin solid tumor phase ib trial: Safety and clinical activity. J Clin Oncol. 2016; 34(15_suppl):5533–533. https://doi.org/10.1200/JCO.2016.34.15_suppl.5533. UR - https://doi.org/10.1200/JCO.2016.34.15_suppl.5533 ID - ref33 ER - TY - STD TI - Varga A, Piha-Paul SA, Ott PA, Mehnert JM, Berton-Rigaud D, Morosky A, Zhao GQ, Rangwala RA, Matei D. Pembrolizumab in patients (pts) with pd-l1-positive (pd-l1+) advanced ovarian cancer: Updated analysis of keynote-028. J Clin Oncol. 2017; 35(15_suppl):5513–513. https://doi.org/10.1200/JCO.2017.35.15_suppl.5513. UR - https://doi.org/10.1200/JCO.2017.35.15_suppl.5513 ID - ref34 ER - TY - STD TI - Pagtés F, Galon J, Dieu-Nosjean MC, Tartour E, Sauttés-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010; 29(8):1093–102. https://doi.org/10.1038/onc.2009.416. UR - https://doi.org/10.1038/onc.2009.416 ID - ref35 ER - TY - JOUR AU - Mlecnik, B. AU - Bindea, G. AU - Kirilovsky, A. AU - Angell, H. K. AU - Obenauf, A. C. AU - Tosolini, M. AU - Church, S. E. AU - Maby, P. AU - Vasaturo, A. AU - Angelova, M. AU - Fredriksen, T. AU - Mauger, S. AU - Waldner, M. AU - Berger, A. AU - Speicher, M. R. AU - Pagès, F. AU - Valge-Archer, V. AU - Galon, J. PY - 2016 DA - 2016// TI - The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis JO - Sci Transl Med VL - 8 UR - https://doi.org/10.1126/scitranslmed.aad6352 DO - 10.1126/scitranslmed.aad6352 ID - Mlecnik2016 ER - TY - STD TI - Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015; 160(1-2):48–61. https://doi.org/10.1016/j.cell.2014.12.033. UR - https://doi.org/10.1016/j.cell.2014.12.033 ID - ref37 ER - TY - STD TI - Giannakis M, Mu XJ, Shukla SA, Qian ZR, Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, Sukawa Y, Stewart C, Rosenberg M, Mima K, Inamura K, Nosho K, Nowak JA, Lawrence MS, Giovannucci EL, Chan AT, Ng K, Meyerhardt JA, Van Allen E. M., Getz G, Gabriel SB, Lander ES, Wu CJ, Fuchs CS, Ogino S, Garraway LA. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell Rep. 2016; 15(4):857–65. https://doi.org/10.1016/j.celrep.2016.03.075. UR - https://doi.org/10.1016/j.celrep.2016.03.075 ID - ref38 ER - TY - STD TI - Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002; 3(11):991–8. https://doi.org/10.1038/ni1102-991. UR - https://doi.org/10.1038/ni1102-991 ID - ref39 ER - TY - STD TI - Martin SD, Brown SD, Wick DA, Nielsen JS, Kroeger DR, Twumasi-Boateng K, Holt RA, Nelson BH. Low mutation burden in ovarian cancer may limit the utility of neoantigen-targeted vaccines. PLOS ONE. 2016; 11(5):0155189. https://doi.org/10.1371/journal.pone.0155189. UR - https://doi.org/10.1371/journal.pone.0155189 ID - ref40 ER - TY - STD TI - McGranahan N, Furness AJS, Rosenthal R, Ramskov S, Lyngaa R, Saini SK, Jamal-Hanjani M, Wilson GA, Birkbak NJ, Hiley CT, Watkins TBK, Shafi S, Murugaesu N, Mitter R, Akarca AU, Linares J, Marafioti T, Henry JY, Allen EMV, Miao D, Schilling B, Schadendorf D, Garraway LA, Makarov V, Rizvi NA, Snyder A, Hellmann MD, Merghoub T, Wolchok JD, Shukla SA, Wu CJ, Peggs KS, Chan TA, Hadrup SR, Quezada SA, Swanton C. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 2016; 351(6280):1463–1469. https://doi.org/10.1126/science.aaf1490. UR - https://doi.org/10.1126/science.aaf1490 ID - ref41 ER -